Programme Timings are subject to change
| 10:00 - 10:05 | Welcome | Chair |
| 10:05 - 10:40 | How to identify risk factors for resistance in and the role of WGS in diagnostic stewardship for TB. | Dr Esther Robinson, Head of TB Unit, Consultant Microbiologist and Clinical Lead, UKHSA, UK |
| 10:40 - 11:15 |
Therapeutic drug monitoring |
Prof Alasdair MacGowan, Consultant in Infection Research, North Bristol NHS Trust, UK
|
| 11:15 - 11:30 | Break |
|
| 11:30 - 12:05 |
AMR in neonatal and paediatric care |
Dr. Beatriz Larru Martinez, Director of Infection Prevention & Control, Alder Hey Children's NHS Foundation Trust, UK |
| 12:05 - 12:40 |
Antimicrobial resistance in invasive Group A Strep and implications for antimicrobial stewardship |
Dr Deidre Brady, Mater Misericordiae University Hospital, Ireland |
| 12:40 - 13:30 |
Lunch |
|
| 13:30 - 14:05 |
Molecular epidemiology of Gram-negatives |
Dr Michaela Day, Lead Clinical Scientist - Opportunistic Pathogen Section - UKHSA, UK |
| 14:05 - 14:40 | Treating infections caused by carbapenemase-producing Enterobacterales (CPE) approaches to antimicrobial stewardship’ | Dr Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster, NHS Foundation Trust, UK |
| 14:40- 14:55 | Break | |
| 14:55 - 15:30 | Presentation title to be announced | Bobson Derrick Fofanah, Infection Prevention and Control Officer, World Health Organisation, Sierra Leone |
| 15:30 - 16:05 | Current and emerging antifungal resistance threats | Dr Riina Richardson, Consultant Medical Mycologist, Manchester University NHS Foundation Trust, UK |
| 16:05 - 16:10 | Summary and close |